Chromocenter

About:

Chromocenter is a biopharmaceuticals manufacturing company that develops protein production courses and chromosome analysis services.

Website: http://chromocenter.com

Twitter/X: chromocenter_jp

Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, Osaka University Venture Capital, QB Capital, Shinkin Capital

Description:

Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals

Total Funding Amount:

558M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2005-01-01

Contact Email:

chromo(AT)chromocenter.com

Founders:

Takayuki Matsuoka

Number of Employees:

1-10

Last Funding Date:

2021-03-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai